Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Prev Med ; 104: 4-6, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28232101

ABSTRACT

In November 2012 Colorado voters approved legalized recreational marijuana. On January 1, 2014 Colorado became the first state to allow legal sales of non-medical marijuana for adults over the age of 21. Since that time, the state has been monitoring potential impacts on population health. In this paper we present lessons learned in the first three years following legal sales of recreational marijuana. These lessons pertain to health behaviors and health outcomes, as well as to health policy issues. Our intent is to share these lessons with other states as they face the prospect of recreational marijuana legalization.


Subject(s)
Cannabis , Health Impact Assessment , Legislation, Drug , Marijuana Smoking/legislation & jurisprudence , Recreation , Adult , Colorado , Commerce , Health Policy , Humans
2.
Am J Public Health ; 106(1): 21-7, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26562117

ABSTRACT

On January 1, 2014, Colorado became the first state in the nation to sell legal recreational marijuana for adult use. As a result, Colorado has had to carefully examine potential population health and safety impacts as well as the role of public health in response to legalization. We have discussed an emerging public health framework for legalized recreational marijuana. We have outlined this framework according to the core public health functions of assessment, policy development, and assurance. In addition, we have discussed challenges to implementing this framework that other states considering legalization may face.


Subject(s)
Cannabis , Health Education/standards , Health Impact Assessment/methods , Legislation, Drug , Population Surveillance/methods , Public Health/legislation & jurisprudence , Adult , Colorado , Commerce/legislation & jurisprudence , Dronabinol/adverse effects , Dronabinol/economics , Dronabinol/supply & distribution , Health Education/legislation & jurisprudence , Health Education/organization & administration , Humans , Policy Making , Psychotropic Drugs/adverse effects , Psychotropic Drugs/economics , Psychotropic Drugs/supply & distribution
SELECTION OF CITATIONS
SEARCH DETAIL